Overview of Genetic Dilated Cardiomyopathy (DCM)

Precision Cardiovascular Care 2024: Transitioning Care from Phenotypes to Genotypes

Q. Bui

Using Cardiac MRI to Assess Progression and Treatment Response

The France Foundation

D. Kwon

Top 5 Arrhythmias You Need to Know

Joel Gorfinkel

PET Imagining in Cardiac Amyloidosis

NYU Langone

S. Dorbala

HFpEF or Amyloidosis? The Right Therapies for Right Patients

Scripps Health

M. Kittleson

Hypertrophic Cardiomyopathy: Diagnosis and Treatment

Scripps Health

R. C. Mohan

Hypertrophic Cardiomyopathy: the Past, the Present, and the Future

Canadian Collaborative Research Network

E. Braunwald

Patient Perspective: Cardiac Amyloidosis

Scripps Health

M. Nichols

Cardiac Amyloidosis: A New Era of Diagnostics and Therapeutics

UCLA Health

D. Vucicevic

Cardiac Amyloidosis: An Overlooked but Treatable Cause of HFpEF

Inova Heart and Vascular Institute - Advanced Heart Failure Symposium

SOHO 2022: Amyloidosis - Update and How To Use Novel Agents

SOHO 2022 Tenth Annual Meeting

S. Lentzsch

Amyloidosis Types and Pathophysiology

Houston Methodist

B. Trachtenberg

Ischemic Ventricular Tachycardia

Scripps Health

D. Gibson

Pathophysiologic Relationships between Arrhythmia and Cardiomyopathy…

Brian Olshansky

Obstructive Hypertrophic Cardiomyopathy vs. Primary Mitral Valve Pro…

Piedmont's Marcus Heart Valve Center

R. Martin, F. Milla

Emerging Therapies in Cardiac Amyloidosis

NYU Langone

M. Hanna

Hypertrophic Cardiomyopathy: MRI to Mavacamten

Scripps Health

J. Gonzalez

New Diagnostic and Treatment Strategies in Cardiac Amyloidosis

Canadian Collaborative Research Network

M. Davis

ESC 2024 Insights: Effect of Aficamten on Cardiac Structure and Func…

ESC 2024 Insights

A. Masri

Update on Hypertrophic Cardiomyopathy: How to Use Imaging for Diagno…

37th Annual Advances in Heart Disease

T. Abraham